Zoya Kingsbury
Overview
Explore the profile of Zoya Kingsbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
5249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelan R, Mijuskovic M, Hughes M, Becq J, Kingsbury Z, Tsogka E, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40032506
Aims: Whole-genome sequencing (WGS) is beginning to be applied to cancer samples in the clinical setting. This ideally requires high-quality, minimally degraded DNA of high tumour cell content, while retaining...
2.
Walsh R, Mauleekoonphairoj J, Mengarelli I, Bosada F, Verkerk A, van Duijvenboden K, et al.
Circulation
. 2024 Oct;
151(1):31-44.
PMID: 39391988
Background: Brugada syndrome (BrS) is a cardiac arrhythmia disorder that causes sudden death in young adults. Rare genetic variants in the gene encoding the Na1.5 sodium channel and common noncoding...
3.
Basyuni S, Heskin L, Degasperi A, Black D, Koh G, Chmelova L, et al.
Nat Commun
. 2024 Sep;
15(1):7731.
PMID: 39231944
Whole genome sequencing (WGS) provides comprehensive, individualised cancer genomic information. However, routine tumour biopsies are formalin-fixed and paraffin-embedded (FFPE), damaging DNA, historically limiting their use in WGS. Here we analyse...
4.
McBride D, Fielding C, Newington T, Vatsiou A, Fischl H, Bajracharya M, et al.
Int J Neonatal Screen
. 2023 Sep;
9(3).
PMID: 37754778
The collection of dried blood spots (DBS) facilitates newborn screening for a variety of rare, but very serious conditions in healthcare systems around the world. Sub-punches of varying sizes (1.5-6...
5.
Gao Q, Ryan S, Iacobucci I, Ghate P, Cranston R, Schwab C, et al.
Blood
. 2023 May;
142(8):711-723.
PMID: 37216686
Intrachromosomal amplification of chromosome 21 defines a subtype of high-risk childhood acute lymphoblastic leukemia (iAMP21-ALL) characterized by copy number changes and complex rearrangements of chromosome 21. The genomic basis of...
6.
Ryan S, Peden J, Kingsbury Z, Schwab C, James T, Polonen P, et al.
Leukemia
. 2023 Jan;
37(3):518-528.
PMID: 36658389
Childhood B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by recurrent genetic abnormalities that drive risk-directed treatment strategies. Using current techniques, accurate detection of such aberrations can be challenging, due to...
7.
Schwab C, Cranston R, Ryan S, Butler E, Winterman E, Hawking Z, et al.
Leukemia
. 2022 Dec;
37(3):529-538.
PMID: 36550215
Incorporating genetics into risk-stratification for treatment of childhood B-progenitor acute lymphoblastic leukaemia (B-ALL) has contributed significantly to improved survival. In about 30% B-ALL (B-other-ALL) without well-established chromosomal changes, new genetic...
8.
Tirtakusuma R, Szoltysek K, Milne P, Grinev V, Ptasinska A, Chin P, et al.
Blood
. 2022 Jul;
140(17):1875-1890.
PMID: 35839448
The fusion gene MLL/AF4 defines a high-risk subtype of pro-B acute lymphoblastic leukemia. Relapse can be associated with a lineage switch from acute lymphoblastic to acute myeloid leukemia, resulting in...
9.
Stodolna A, He M, Vasipalli M, Kingsbury Z, Becq J, Stockton J, et al.
Genome Med
. 2021 Feb;
13(1):33.
PMID: 33632293
Background: Clinical-grade whole-genome sequencing (cWGS) has the potential to become the standard of care within the clinic because of its breadth of coverage and lack of bias towards certain regions...
10.
Lau E, McCoy P, Reeves F, Chow K, Clarkson M, Kwan E, et al.
Genome Med
. 2020 Aug;
12(1):72.
PMID: 32807235
Background: DNA originating from degenerate tumour cells can be detected in the circulation in many tumour types, where it can be used as a marker of disease burden as well...